BMJ 2001;322:986-988 ( 21 April )

Education and debate

Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria

Nicholas J Wareham, clinical scientist, Simon J Griffin, lecturer. 

Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge CB2 2SR

Correspondence to: N Wareham njw1004@medschl.cam.ac.uk

The first 150 words of the full text of this article appear below.

The high prevalence of undiagnosed diabetes¹ and the proportion of cases with evidence of complications at diagnosis ^{2 3} undoubtedly create a strong imperative for screening. In the United Kingdom, the National Screening Committee has the task of providing advice about established and newly proposed screening programmes and aims to evaluate these against specified criteria.⁴ This article evaluates screening for type 2 diabetes in relation to these criteria.

Table Removed (Available Only in the Full Text)

	The condition

The first group of issues considered by the National Screening Committee relates to the condition for which screening is proposed. In the case of type 2 diabetes, these issues are relatively uncontroversial. The scale of morbidity and mortality attributable to diabetes is not in question,⁵ and the longitudinal examination of cohorts has established the overall course of the condition.⁶ Undiagnosed diabetes is common⁷; it is not generally characterised by recognised symptoms and is as strongly associated with future risk as diagnosed diabetes.⁸ Up to 25% . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial

Helen C Eborall, Simon J Griffin, A Toby Prevost, Ann-Louise Kinmonth, David P French, and Stephen Sutton
BMJ 2007 335: 486. [Abstract] [Full Text] [PDF]

Screening for diabetes

Ronald P Stolk
BMJ 2007 335: 457-458. [Extract] [Full Text] [PDF]

Screening for type 2 diabetes

Paul Streets, Michael Berger, Mary Walker, Andy Thomson, Peter H Whincup, Nicholas J Wareham, and Simon J Griffin
BMJ 2001 323: 453. [Extract] [Full Text]

This article has been cited by other articles:

• de Marco, R. (2008). What evidence could validate the definition of COPD?. Thorax 63: 756-757 [Full text]  
• Goyder, E, Wild, S, Fischbacher, C, Carlisle, J, Peters, J (2008). Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Fam Pract 0: cmn054v1-cmn054 [Abstract] [Full text]  
• Agwu, J C. (2008). Screening for type 2 diabetes mellitus in children and adolescents. British Journal of Diabetes & Vascular Disease 8: 163-168 [Abstract]  
• Balkau, B. (2008). Screening for Diabetes. Diabetes Care 31: 1084-1085 [Full text]  
• Eborall, H. C, Griffin, S. J, Prevost, A T., Kinmonth, A.-L., French, D. P, Sutton, S. (2007). Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 335: 486-486 [Abstract] [Full text]  
• Stolk, R. P (2007). Screening for diabetes. BMJ 335: 457-458 [Full text]  
• Klein Woolthuis, E. P, de Grauw, W. J., van Gerwen, W. H., van den Hoogen, H. J., van de Lisdonk, E. H, Metsemakers, J. F., van Weel, C. (2007). Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record. Fam Pract 0: cmm018v2- [Abstract] [Full text]  
• Thomas, C., Hypponen, E., Power, C. (2006). Type 2 diabetes mellitus in midlife estimated from the cambridge risk score and body mass index.. Arch Intern Med 166: 682-688 [Abstract] [Full text]  
• Icks, A., Haastert, B., Gandjour, A., John, J., Lowel, H., Holle, R., Giani, G., Rathmann, W. (2004). Cost-Effectiveness Analysis of Different Screening Procedures for Type 2 Diabetes: The KORA Survey 2000. Diabetes Care 27: 2120-2128 [Abstract] [Full text]  
• Young, E H, Wareham, N J (2004). Screening for coeliac disease: what evidence is required before population programmes could be considered?. Arch. Dis. Child. 89: 499-500 [Full text]  
• Hoerger, T. J., Harris, R., Hicks, K. A., Donahue, K., Sorensen, S., Engelgau, M. (2004). Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis. ANN INTERN MED 140: 689-699 [Abstract] [Full text]  
• Holt, R. I. G. (2004). Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists. Br. J. Psychiatry 184: s55-s63 [Abstract] [Full text]  
• Greaves, C., Stead, J., Hattersley, A., Ewings, P, Brown, P, Evans, P. (2004). A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care. Fam Pract 21: 57-62 [Abstract] [Full text]  
• Buckley, M. G, Liversedge, S. N, Dean, J. D (2003). Diabetes services in primary care: are we prepared for the diabetes NSF?. British Journal of Diabetes & Vascular Disease 3: 418-423 [Abstract]  
• Davidson, M. B. (2003). The case for screening for type 2 diabetes in selected populations. BMJ 327: E38-39 [Full text]  
• Broom, D. H (2003). Familiarity breeds neglect? Unanticipated benefits of discontinuous primary care. Fam Pract 20: 503-507 [Abstract] [Full text]  
• Harris, R., Donahue, K., Rathore, S. S., Frame, P., Woolf, S. H., Lohr, K. N. (2003). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 138: 215-229 [Abstract] [Full text]  
• Spijkerman, A. M.W., Adriaanse, M. C., Dekker, J. M., Nijpels, G., Stehouwer, C. D.A., Bouter, L. M., Heine, R. J. (2002). Diabetic Patients Detected by Population-Based Stepwise Screening Already Have a Diabetic Cardiovascular Risk Profile. Diabetes Care 25: 1784-1789 [Abstract] [Full text]  
• Colagiuri, S., Cull, C. A., Holman, R. R. (2002). Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated With Improved Outcomes?: U.K. Prospective Diabetes Study 61. Diabetes Care 25: 1410-1417 [Abstract] [Full text]  
• Park, P.J., Griffin, S.J., Sargeant, L., Wareham, N. J. (2002). The Performance of a Risk Score in Predicting Undiagnosed Hyperglycemia. Diabetes Care 25: 984-988 [Abstract] [Full text]  
• Lawrence, J. M, Bennett, P., Young, A., Robinson, A. M (2001). Screening for diabetes in general practice: cross sectional population study. BMJ 323: 548-551 [Abstract] [Full text]  
• Streets, P., Berger, M., Walker, M., Thomson, A., Whincup, P. H, Wareham, N. J, Griffin, S. J (2001). Screening for type 2 diabetes. BMJ 323: 453-453 [Full text]  
• Davies, M. J (2001). A National Service Framework for diabetes. British Journal of Diabetes & Vascular Disease 1: 123-125  

Rapid Responses:

Read all Rapid Responses

Screening for type 2 diabetes

Habib-ur-Rehman
bmj.com, 22 Apr 2001 [Full text]

Screening for Type 2 diabetes mellitus

Michael Berger
bmj.com, 3 May 2001 [Full text]

The new burden of diabetic care

Mary Walker
bmj.com, 11 May 2001 [Full text]